Bionano Genomics, Inc. (BNGO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Bionano Genomics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.32x | -0.29x | -0.28x | -3.25x | -11.65x | -7.97x |
| P/B Ratio | 0.19x | 0.93x | 0.68x | 1.73x | 2.50x | 9.34x |
| P/S Ratio | 0.29x | 1.07x | 1.82x | 15.49x | 46.95x | 38.52x |
| Profitability | ||||||
| Gross Margin | 22.0% | 1.2% | 26.5% | 21.4% | 21.5% | 32.6% |
| Operating Margin | -116.9% | -337.9% | -596.0% | -473.7% | -428.8% | -453.4% |
| Net Margin | -92.6% | -364.0% | -643.7% | -476.9% | -402.8% | -483.4% |
| EBITDA Margin | -82.8% | -316.7% | -591.4% | -432.8% | -410.7% | -418.3% |
| Liquidity | ||||||
| Current Ratio | 1.98x | 1.06x | 1.40x | 4.38x | 12.47x | 5.23x |
| Quick Ratio | 1.74x | 0.76x | 1.17x | 3.55x | 11.91x | 4.86x |
| Leverage | ||||||
| Debt/Equity | 0.16x | 0.77x | 0.83x | 0.05x | 0.03x | 0.47x |
YoY = year-over-year change. Source: FMP..